DD291560A5 - Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten - Google Patents

Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten Download PDF

Info

Publication number
DD291560A5
DD291560A5 DD90337249A DD33724990A DD291560A5 DD 291560 A5 DD291560 A5 DD 291560A5 DD 90337249 A DD90337249 A DD 90337249A DD 33724990 A DD33724990 A DD 33724990A DD 291560 A5 DD291560 A5 DD 291560A5
Authority
DD
German Democratic Republic
Prior art keywords
nmr
calculated
formula
crystallized
tlc
Prior art date
Application number
DD90337249A
Other languages
German (de)
English (en)
Inventor
Kishor A Desai
Gene M Bright
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD291560A5 publication Critical patent/DD291560A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DD90337249A 1989-01-23 1990-01-22 Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten DD291560A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000275 WO1990008148A1 (en) 1989-01-23 1989-01-23 Bis-aza-bicyclic anxiolytic agents

Publications (1)

Publication Number Publication Date
DD291560A5 true DD291560A5 (de) 1991-07-04

Family

ID=22214801

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90337249A DD291560A5 (de) 1989-01-23 1990-01-22 Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten

Country Status (38)

Country Link
US (1) US5122525A (da)
EP (1) EP0380217B1 (da)
JP (1) JPH0643427B2 (da)
KR (1) KR910009289B1 (da)
CN (1) CN1022186C (da)
AP (1) AP128A (da)
AR (1) AR246969A1 (da)
AT (1) ATE82574T1 (da)
AU (1) AU614214B2 (da)
BA (1) BA98302A (da)
BG (1) BG51046A3 (da)
CA (1) CA2008108C (da)
CZ (1) CZ277698B6 (da)
DD (1) DD291560A5 (da)
DE (1) DE69000467T2 (da)
DK (1) DK0380217T3 (da)
EG (1) EG19306A (da)
ES (1) ES2053094T3 (da)
FI (1) FI95381C (da)
GR (1) GR3006925T3 (da)
HU (1) HU215154B (da)
IE (1) IE62670B1 (da)
IL (1) IL93073A (da)
IS (1) IS1667B (da)
MA (1) MA21735A1 (da)
MX (1) MX19222A (da)
MY (1) MY104861A (da)
NO (1) NO175978C (da)
NZ (1) NZ232168A (da)
OA (1) OA10041A (da)
PL (1) PL163836B1 (da)
PT (1) PT92919B (da)
RO (1) RO110142B1 (da)
RU (1) RU2015977C1 (da)
SK (1) SK279339B6 (da)
WO (2) WO1990008148A1 (da)
YU (1) YU47554B (da)
ZA (1) ZA90430B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
WO1992000075A1 (en) * 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
CA2099563C (en) * 1991-01-31 1998-09-29 Charles W. Murtiashaw Preparation of (7s, trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl) octahydro-2h-pyrido[1,2-a]pyrazine
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
ATE150453T1 (de) * 1991-02-27 1997-04-15 Pfizer Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten
US5311195A (en) * 1991-08-30 1994-05-10 Etak, Inc. Combined relative and absolute positioning method and apparatus
CA2118936A1 (en) * 1991-09-25 1993-04-01 Gene M. Bright Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
JP2753146B2 (ja) * 1992-06-16 1998-05-18 ファイザー・インコーポレーテッド ビス−アザー二環式抗不安薬の製法および中間体
AU5291793A (en) * 1992-09-24 1994-04-12 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
IL104506A (en) * 1993-01-25 1997-11-20 Israel State Fast changing heating- cooling device and method, particularly for cryogenic and/or surgical use
US5637713A (en) * 1993-08-20 1997-06-10 Pfizer Inc. Process for preparing trans-piperidine-2,5-dicarboxylates
US5455350A (en) * 1993-10-13 1995-10-03 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
IL107460A (en) * 1993-11-01 1999-06-20 Israel State Controlled cryogenic contact system
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
ATE209648T1 (de) * 1994-09-30 2001-12-15 Pfizer 2,7,-substituierte octahydro-1h-pyrido(1,2- a)pyrazin derivate
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
EP0874849B1 (en) * 1995-12-21 2001-09-19 Pfizer Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
CZ434998A3 (cs) * 1996-07-01 1999-11-17 Pfizer Inc. Způsob výroby (7S,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)oktahydro-2H-pyrido[1,2-a]-pyrazinu
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
US6251893B1 (en) * 1998-06-15 2001-06-26 Nps Allelix Corp. Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6670476B2 (en) 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
MXPA05009660A (es) * 2003-03-12 2005-10-20 Pfizer Prod Inc Derivados azabiciclicos de piridiloximetilo y bencisoxazol.
EP1633756B1 (en) 2003-04-09 2008-12-24 Biogen Idec MA Inc. A2a adenosine receptor antagonists
DE602004028150D1 (de) * 2003-11-26 2010-08-26 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
MXPA06013762A (es) * 2004-05-27 2007-02-08 Warner Lambert Co Combinacion de atomoxetina y un agonista del receptor 5t1a para el tratamiento de trastorno de hiperactividad con deficit de atencion y otros trastornos.
US7658206B2 (en) 2006-12-05 2010-02-09 Kohler Co. Plumbing valve with stick control handle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4339579A (en) * 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
US4400511A (en) * 1982-05-07 1983-08-23 American Home Products Corporation 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
US4414389A (en) * 1982-05-25 1983-11-08 American Home Products Corporation 4-Substituted-piperidino carboxamides
US4517187A (en) * 1982-10-18 1985-05-14 Pennwalt Corporation 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3409440A1 (de) * 1984-03-15 1985-09-26 Bayer Ag, 5090 Leverkusen Imidazo(1,5-a)pyridyl-methan- und imidazo(1,5-b)pyridazinylmethan-derivate, ihre herstellung und sie enthaltende aufzeichnungsmaterialien
IT1204803B (it) * 1986-02-17 1989-03-10 Acraf Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
JP2668259B2 (ja) * 1988-02-18 1997-10-27 塩野義製薬株式会社 複素環化合物および抗潰瘍剤
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
ZA90430B (en) 1991-08-28
AP128A (en) 1991-03-20
NO175978B (no) 1994-10-03
CS29990A3 (en) 1992-11-18
BA98302A (bs) 2001-09-14
MY104861A (en) 1994-06-30
CZ277698B6 (en) 1993-03-17
ATE82574T1 (de) 1992-12-15
CA2008108C (en) 1995-08-08
AP9000158A0 (en) 1990-01-31
EP0380217B1 (en) 1992-11-19
US5122525A (en) 1992-06-16
NZ232168A (en) 1991-08-27
KR900011774A (ko) 1990-08-02
FI95381B (fi) 1995-10-13
WO1990008144A1 (en) 1990-07-26
HU215154B (hu) 2000-09-28
OA10041A (en) 1996-10-14
DE69000467D1 (de) 1992-12-24
RU2015977C1 (ru) 1994-07-15
IE62670B1 (en) 1995-03-08
JPH02233681A (ja) 1990-09-17
WO1990008148A1 (en) 1990-07-26
SK279339B6 (sk) 1998-10-07
PL163836B1 (pl) 1994-05-31
AU614214B2 (en) 1991-08-22
DK0380217T3 (da) 1992-12-14
BG51046A3 (en) 1993-01-15
PT92919B (pt) 1995-12-29
MA21735A1 (fr) 1990-10-01
YU47554B (sh) 1995-10-03
GR3006925T3 (da) 1993-06-30
FI95381C (fi) 1996-01-25
IS3529A7 (is) 1990-07-24
EG19306A (en) 1995-01-31
YU11190A (sh) 1993-05-28
NO912863D0 (no) 1991-07-22
FI913510A0 (fi) 1991-07-22
CN1044464A (zh) 1990-08-08
NO175978C (no) 1995-01-11
AU4867990A (en) 1990-07-26
MX19222A (es) 1993-12-01
CA2008108A1 (en) 1990-07-23
NO912863L (no) 1991-07-22
EP0380217A1 (en) 1990-08-01
CN1022186C (zh) 1993-09-22
AR246969A1 (es) 1994-10-31
KR910009289B1 (ko) 1991-11-09
RO110142B1 (ro) 1995-10-30
IS1667B (is) 1997-11-14
HUT63163A (en) 1993-07-28
JPH0643427B2 (ja) 1994-06-08
PT92919A (pt) 1990-07-31
ES2053094T3 (es) 1994-07-16
IL93073A (en) 1994-05-30
IE900225L (en) 1990-07-23
DE69000467T2 (de) 1993-04-01

Similar Documents

Publication Publication Date Title
DD291560A5 (de) Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten
DE3005164C2 (de) 1,1-Dioxopenicillanoyloxymethyl-6-(D-α-amino-α-phenylacetamido)-penicillanat, Verfahren zu seiner Herstellung und es enthaltendes Arzneimittel
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE2915318A1 (de) Cycloalkyltriazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0063381A1 (de) Neue Pyrazolo(3,4-d)pyrimidine, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE60026883T2 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69824195T2 (de) Dipyridoimidazolderivate zur behandlung von störungen des zentralen nervensystems
DE68907392T2 (de) Dysmnesie modifizierende Arzneimittel.
DE2647041C2 (de) 3-Aminomethylen-6,7-dimethoxy-2- methyl-4-oxo-1,2,3,4-tetrahydro-1-chinolincarbonsäureäthylester
DE69726749T2 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
DE2460929C2 (da)
EP0180115A2 (de) 1,2,4-Triazolo-carbamate und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE2229845B2 (de) 6-o-Halogenphenyl-4H-s-triazolo [3,4-c] thieno [2,3e] [1,4] diazepine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Massen
DE69106516T2 (de) Pyridopyrazinderivate zur behandlung von drogenmissbrauch und -sucht.
DE4131584A1 (de) Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
DE68905363T2 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE69125962T2 (de) 3H,6H-1,4,5a,8a-Tetraazaacenaphthylen-3,5-(4H)dione
DE3643666A1 (de) Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0172526B1 (de) Neue Benzodiazepine, Verfahren zu ihrer Herstellung sowie ihre Verwendung
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DD263531A5 (de) Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
DD294944A5 (de) Verfahren zur herstellung von 1,2,4-triazolo[4,3-a]pyrazinen
EP0167045A1 (de) Benzo (c)(1,8)naphthyridine, Verfahren zu ihrer Herstellung und ihre Verwendung sowie diese Verbindungen enthaltende Zubereitungen
DE69013396T2 (de) Triazolo[4,5-c]pyridinderivate mit krampflindernder Wirkung.
DE2634910A1 (de) Quartaere kondensierte heterocyclische salze sowie antidiabetika

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee